McCamish Mark Anthony has filed 20 insider transactions across 2 companies since August 2023.
Most recent transaction: a disposition of 11000 shares of AVADEL PHARMACEUTICALS PLC ($AVDL) on February 12, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Ordinary Shares | 22000 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.02% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Ordinary Shares | 67025 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.07% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.06% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.05% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.03% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 4, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | G | Ordinary Shares | 67025 | $0.00 | 89,025.0000 | 101,276,000 | 42.95% | 0.07% |
| Feb. 4, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | G | Ordinary Shares | 67025 | $0.00 | 89,025.0000 | 101,276,000 | 304.66% | 0.07% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | A | Ordinary Shares | 11000 | $0.00 | 89,025.0000 | 95,141,000 | 14.10% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 95,141,000 | 9999.99% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | A | Ordinary Shares | 11000 | $0.00 | 78,025.0000 | 80,174,000 | 16.41% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 80,174,000 | 9999.99% | 0.01% |
| Jan. 5, 2024 | Rafael Holdings, Inc. | $RFL | McCamish Mark Anthony | Director | A | Class B Common Stock, par value $.01 per share | 27655 | $1.81 | 60,241.0000 | 23,644,647 | 84.87% | 0.12% |
| Dec. 28, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | S | ADSs | 75000 | $14.53 | 67,025.0000 | 60,094,000 | 52.81% | 0.12% |
| Aug. 11, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | S | ADSs | 28975 | $14.93 | 142,025.0000 | 60,094,000 | 16.94% | 0.05% |
| Aug. 1, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | McCamish Mark Anthony | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 60,094,000 | 9999.99% | 0.05% |